Abstract
Since its discovery in 1964 (1) and implication as the main cause of the infectious mononucleosis (IM) syndrome (2), the Epstein-Barr virus (EBV) has become a common archetype of human latent viral infections (3). This has been ascribed to its infection of B lymphocytes (4) and a resultant permanent viral carrier state (3). These genome carrying cells may give rise to continuous EBV-containing lymphoblastoid cell lines in in vitro cultures established from the peripheral blood and lymph node lymphocytes of seropositive individuals (5). With the characterization of the specific antibody responses in IM (6), their application in the elucidation of atypical cases of EBV infection became evident (7), particularly in children (8) and in 50–60% of adults where the minimal criteria for the diagnosis of IM (9) are not fulfilled (10,11). Given the high incidence of exposed individuals (80% by late adolescence), the recognized tendency of herpes viruses to reactivation (3), the persistent carrier state, and the predisposition to atypical infections, it might be expected that recurrent or prolonged atypical EBV infections would be commonly reported.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Epstein, M.A., Achong, B.G., and Barr, Y.M. Virus particle in cultured lymphoblasts from Burkitt’s lymphoma. Lancet, i:702, 1964.
Henle, G., Henle, W., and Diehl, V. Relation of Burkitt’s tumour associated with herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA, 59:94, 1968.
Epstein, M.A. and Achong, B.G. Various forms of EBV infection in man: estalished facts and a general concept. Lancet, ii:836, 1973.
Pattengale, P.K., Smith, R.W., and Gerber, P. Selective transformation of B lymphocytes by EB virus. Lancet, ii:93, 1973.
Nilsson, K., Klein, G., Henle, W., and Henle, G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer, 8:443, 1971.
Henle, W., Henle, G.E., and Horwitz, C.A. Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Human Path., 5:551, 1974.
Hallee, T.J., Evans, A.S., Niederman, J.C., Brooks, C.M., and Voegtly, J.H. IM at the U.S. military academy. Yale J. Biol. Med., 3:182, 1974.
Karzon, D.T. Infectious mononucleosis. Adv. Pediat., 22:231, 1976.
Horwitz, C.A. Practical approach to the diagnosis of infectious mononucleosis. Postgraduate Med., 65:179, 1979.
Niederman, J.C., Evans, A.S., Subrahmanyah, L., and McCollum, R.W. Prevalence, incidence and persistence of EB virus antibody in young adults. N. Engl. J. Med., 282:361, 1970.
Joint investigation by University Health Physicians and P.H.L.S. Laboratories. Infectious mononucleosis and its relationship to EBV antibody. Br. Med. J., 4:643, 1971.
Paterson, J.K. and Pinninger, J.L. Case of recurrent infectious mononucleosis. Br. Med. J., 2:476, 1955.
Bender, C.E. Recurrent mononucleosis. J. Am. Med. Assoc., 182:954, 1962.
Kaufman, R.E. Recurrences of infectious mononucleosis. Amer. Practit., 1:673, 1950.
Chang, R.S. EBV virus-seropositive person is susceptible to infectious mononucleosis. N. Engl. J. Med., 292:925, 1975.
Stevens, D.A., Pry, T.W., and Manaker, R.A. Infectious mononucleosis — Always a primary infection with herpestype virus? J. Natl. Cancer Inst., 44:533, 1970.
Horwitz, C.A., Henle, W., Henle, G. et al. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the EB virus-induced early antigen complex. Am. J. Med., 58:330, 1975.
Banatvala, J.E., Best, J.M., and Wallter, D.K. EBV-specific IgM in infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma. Lancet, i:1205, 1972.
Askinazi, C., Cole, F.S., and Brosch, J.L. Positive differential heterophil antibody tests — persistence in a symptomatic patient. J. Am. Med. Assoc, 236: 1492, 1976.
Virelizier, J.L., Lenoir, G., and Griscelli, C. Persistent EBV infection in a child with hypergammaglobulinemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet, ii:231, 1978.
Sakamoto, K., Freed, H.J., and Purtilo, D.T. Antibody responses to EBV in families with the X-linked lymphopro-liferative syndrome. J. Immunol., 125:921, 1980.
Purtilo, D.T., Paquin, L.A., Sakamoto, K., Hutt, L.M., Yang, J.P.W., Sparling, S., Beberman, N., and McAuley, R.A. Persistent transfusion associated infectious mononucleosis with transient acquired immunodeficiency. Am. J. Med., 68:437, 1980.
Masucci, M.G., Szigeti, R., Ernberg, I., Masucci, G., Klein, G., Chessel, J., Sieff, C., Lie, S., Glomstein, A., Businco, L., Henle, W., Henle, G., Pearson, G., Sakamoto, K., and Purtilo, D.T. Cellular immune defects to EBV-determined antigens in young males. Cancer Res., 41:4284, 1981.
Purtilo, D.T., Sakamoto, K., Saemundsen, A.K., Sullivan, J.L., Synnerholm, A.C., Andersson-Anvret, M., Pritchard, J., Sloper, C., Sieff, C., Pincott, J., Pachman, L., Rich, K., Cruzi, F., Cornet, J., Collins, R., Barnes, N., Knight, J., Sandstedt, B., and Klein, G. Documentation of EBV infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res., 41:4226, 1981.
Tobi, M., Morag, A., Ravid, Z. et al. Prolonged atypical illness associated with serological evidence of persistent EBV infection. Lancet, i:61, 1982.
Lennette, E.M. and Schmidt, N.J. (eds.) Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 5th edition, pp. 441–470. Washington, D.C. American Public Health Association, 1979.
Schleupner, C.J. and Overall, J.C. Infectious mononucleosis and EBV. II. Clinical picture, diagnosis, management. Postgrad. Med., 65:95, 1979.
Finch, S.C. Infectious mononucleosis. In: R.L. Carter and H.G. Penman (eds.), Infectious Mononucleosis. pp. 19–46. Oxford and Edinburgh: Blackwell Scientific Publications, 1969.
Cadie, M., Nye, F.J., and Storey, P. Anxiety and depression after infectious mononucleosis. Brit. J. Psychiat., 128:559, 1976.
Hendler, N. and Leary, W. Psychiatric and neurologic sequelae of infectious mononucleosis. Am. J. Psych., 135:842, 1978.
Evans, A.S. Epstein-Barr and infectious mononucleosis. N. Engl. J. Med., 286:836, 1972.
Evans, A.S. Infectious mononucleosis and related syndrome. Am. J. Med. Sci., 276:325, 1978.
Gordon, D.S., Jones, B.M., Browning, S.W., Spira, T.J., and Lawrence, D.N. Persistent polyclonal lymphocytosis of B lymphocytes. N. Engl. J. Med, 307:232 1982.
Evans, A.S., Niderman, J.C, Cenabre, L.C., West, B., and Richards, N.A. A prospective evaluation of heterophile and EBV-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J. Inf. Dis., 132:546, 1975.
Henle, G., Lynette, E.T., Alspaugh, M.A., and Henle, W. Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus specific IgM antibodies. Clin. Exp. Immunol., 36:415, 1979.
Sumaya, C.V. Endogenous reactivation of Epstein-Barr virus infections. J. Inf. Dis., 135:374, 1977.
Ross, C.A.C. and McDavid, R. Specific IgM antibody in serum of patients with herpes-zoster infections. Br. Med. J., 5:522, 1972.
Henle, G., Henle, W., and Klein, G. Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer, 8:272, 1971.
Henle, W., Ho, H.C., Henle, G., and Kwan, H.C. Antibodies to EBV-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors. J. Natl. Cancer Inst., 51: 361, 1973.
Klein, G. and Purtilo, D.T. Summary: symposium on Epstein-Barr virus induced lymphoproliferative disease in immuno-deficient patients. Cancer Res., 41:4302, 1981.
Henle, W. and Henle, G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res., 4l:4222, 1981.
Isaacs, R. Chronic infectious mononucleosis. Blood, 3:898, 1948.
Baron, S. and Dianzani, F. General consideration of the interferon system. Tex. Rep. Biol. Med., 35:1 1977.
Baglioni, C. Interferon-induced enzymatic activities and their role in the antiviral state. Cell, 17:255, 1979.
Minks, M.A., Benvin, S., Maroney, P.A., and Baglioni, C. Synthesis of (2’–5’)-oligo (A) in extracts of interferon-treated HeLa cells. J. Biol. Chem., 254:5058, 1979.
Schattner, A., Wallach, D., Merlin, G., Hahn, T., Levin, S., and Revel, M. Assay of an interferon-induced enzyme in white blood cells as a diagnostic and in viral diseases. Lancet, ii:497, 1981.
Morag, A., Tobi, M., Ravid, Z., Schattner, A., and Revel, M. Elevated [2’–5’]-oligo A synthetase activity in patients with prolonged illness associated with serological evidence of persistent EBV infection. Lancet, i:744, 1982.
Harrison’s Principles of Internal Medicine. 9th Edition Eds. Isselbacher, Adams, Braunwald, Petersdorf, and Wilson. 10: Chills and Fever. R.G. Petersdorf, pp. 60–67, 1980.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Publishing Corporation
About this chapter
Cite this chapter
Tobi, M., Morag, A. (1984). Chronic Mononucleosis. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4760-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4762-0
Online ISBN: 978-1-4684-4760-6
eBook Packages: Springer Book Archive